San Camillo Forlanini Hospital

At San Camillo Forlanini Hospital, research in digestive system diseases focuses on common and complex inflammatory conditions, especially Crohn’s disease and ulcerative colitis. The trials are designed to assess new treatment options, improve long-term disease control, and better understand how to maintain remission in patients with chronic bowel inflammation.

• Studies in Crohn’s disease and ulcerative colitis
• Evaluation of therapies aimed at reducing symptoms and supporting remission
• Research into safer and more durable maintenance strategies

This area reflects the site’s strong clinical activity in gastroenterology and endoscopy, with a clear emphasis on improving everyday care for patients living with inflammatory bowel disease.

The hospital has a broad portfolio in neoplasms and hemic and lymphatic diseases, with trials spanning non-small cell lung cancer, colorectal cancer, cholangiocarcinoma, bladder cancer, and blood cancers such as diffuse large B-cell lymphoma and acute leukemias. These studies mainly test new cancer therapies, compare treatment combinations, and look for better ways to improve survival and disease control.

• Non-small cell lung cancer and other advanced solid tumors
• Colorectal, biliary, and urothelial cancers
• Lymphoma, multiple myeloma, and acute leukemia

Research at this site also includes biomarker-guided oncology, helping match treatment approaches to tumor features and supporting more personalized cancer care.

Trials in cardiovascular diseases and nervous system diseases address major conditions such as stroke, atrial fibrillation, heart failure, myocardial infarction, and hypertension. The main goal is to evaluate therapies that may reduce serious events, improve recovery, and lower the risk of future complications.

• Acute ischemic stroke and high-risk transient ischemic attack
• Atrial fibrillation and prevention of clot-related events
• Heart failure and post-infarction cardiovascular risk

These studies combine treatment evaluation with prevention-focused research, supporting better outcomes for patients with high-risk cardiovascular disease.

Another major research focus is immune system diseases, including systemic lupus erythematosus, lupus nephritis, and immunoglobulin A nephropathy. The trials aim to test new immune-targeted therapies, reduce inflammation, and improve protection of kidney function in chronic autoimmune disease.

• Systemic lupus erythematosus and related disease activity
• Lupus nephritis and IgA nephropathy
• Evaluation of therapies that may improve long-term control and organ protection

This area shows a strong interest in refining treatment for complex immune-mediated conditions where sustained control is essential.

The site also contributes to research in nervous system diseases, especially multiple sclerosis and radiologically isolated syndrome. These studies are intended to assess new therapies, monitor long-term safety, and support earlier and more effective management of chronic neurological disease.

• Relapsing-remitting multiple sclerosis and progressive forms of disease
• Radiologically isolated syndrome
• Testing treatments designed to slow disease activity and improve stability over time

At San Camillo Forlanini Hospital, this research reflects a wider commitment to immune-related neurological care alongside other chronic specialty areas.

Within respiratory tract diseases, the site is active in studies of lung cancer, particularly advanced non-small cell lung cancer and small-cell lung cancer. The trials are focused on testing targeted and immune-based treatments, comparing options for first-line and later-line care, and improving outcomes in advanced disease.

• Advanced non-small cell lung cancer
• Small-cell lung cancer and rare lung tumor types
• Research into more effective and better-tolerated cancer therapies

This is one of the most active therapeutic areas at the hospital, linking oncology expertise with precision medicine approaches.

The trial portfolio also includes studies in musculoskeletal diseases, skin and connective tissue diseases, congenital and neonatal conditions, and broader diagnostic and therapeutic techniques. These projects range from Dupuytren contracture and intestinal malabsorption to research in preterm infants and other supportive care settings, with a focus on improving treatment effectiveness and clinical management.

• Dupuytren contracture and other musculoskeletal conditions
• Intestinal malabsorption and neonatal care research
• Studies aimed at improving diagnostics, symptom control, and supportive treatment

These trials add breadth to the site’s portfolio and show interest in both highly specialized and cross-cutting areas of clinical care.